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Feedback activation of FVIII in plasma
H.C. Hemker
Dept of Biochemistry, Biomedical Centre, Medical Faculty Maastricht,
University of Limburg, Maastricht, The Netherlands
The proteolytic backbone of the coagulation mechanism is well known, but it is
important to remember that it contains a 'sidestep', FVll/thromboplastin
activating FIX (Fig. 1).
There is a pulse of FVll/thromboplastin activity that is shut down by the EpI
mechanism. After this shut-down, the only way to activate FX is via FIX,
which does not decay in plasma when there is no heparin present.
The proteolytic backbone is not the whole story, because the coagulation
factors need to be adsorbed on phospholipids, next to their helper proteins.
For example, FXa activates prothrombin with the help of FVa, and FVIIIa is
the helper enzyme for FIX.
Helper enzymes are not active during circulation in the plasma, but must be
activated from the plasma precursors, usually by thrombin. FXa can also acti-
vate FVIII, but this does not occur in plasma. The feedback reaction from FV,
which might be thought to be as important as that from FVIII, has little
influence in the usual clotting tests. This may be because FVIII must be freed
from von willebrand Factor. Thrombin activates FVIII, which loses its affinity
to vWF, then can attach to the phospholipid, where FIX is waiting for it.
FVIIIa has a double function in this complex. The first is kinetic. compari-
son of the apparent K, and V.u* of factor X activation by FIXa; FIXa plus
calcium; FIXa, calcium and phospholipid (PL); and FIXa, calcium, pL and
FVIII, shows that the apparent K, drops as soon as pL is present, and V."*
rises as soon as FVIII is present (Table).
By adding FIXa to a fixed amount of PL with or without FVIIIa, the Ko of
FIX for PL with and without FVIIIa can be calculated when the kinetic
constants are known. Ko in the presence of FVIIIa is much smaller than in its
absence.
The maior functions of activated FVIIIc, therefore, are to increase V-* of
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Fig. 1: The proteolytic'backbone' of coagulation'
FXformationbyaboutl0,000-fold,andtopromotetheassemblyofFlXaand
Table:EffectsoftheaccessorycomponentsonkineticparemetersofFXartivation.
Factor X activating mixture V.*(mote Xa' min-l ' mole IXa-l)
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IXa, CaCl2, PL (10PM)
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VIIIa (11U/ml)
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Fig. 2: Time course of FVIII activation at different thrombin concentrations.
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Fig. 3: Thrombin generation by FIXa activated plasma. l-l : Control; H :
150 p.M Hirudin; A-A : 300nM Hirudin.
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!!S:_!t _ Effect of heparin on the generation of FIXa in plasma. tD-| : Control; A-A :UFH S}nglml; A-A : 100nglml; o_O: 175 ng/ml.
thrombin. The rise in activity is itself abolished by inhibiting thrombin by
hirudin (Fig. 3).
In plasma, hirudin shuts off the feedback activation of FVIII in a very
effective way. The feedback activation by FX in plasma is not a physiological
pathway but it does occur in purified systems.
The pathway of APTT, i.e. activation of FIX by the contact factors, is a
tess sensitive to thrombin inhibition than activation of FVI[.
FX back-activates FVIII in a purified system. we measured FVIIIa in
In normal plasma, therefore, when FXa is added, it first disappears, then
reaPPears because it is goneratad. If the system has no MIII, only rhe
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Fig. 5: The initiation of coagulation.
ing reactions must be get rid of in any system in which FVIIIa is to be measured
in plasma.
We achieved this in a one-step system, by adding an excess of chromogenic
substrate for FXa which avoids the inactivation of FXa by ATIII or the
activation of FVIII. There is a quadratic rise in colour, which can be analyzed
to give a good standard curve for FVIII estimation in plasma'
Some drugs act directly on activation of FVIII, one being pentosan polysul-
phate. This drug also inactivates FVa, and boosts heparin co-factor II and
AIII.
One way to show the importance of FVIII feedback is the mode of action of
heparin in the intrinsic system. The appearance of FIXa with time, with and
wiihout heparin, is crucial (Fig. a). FIXa will not decay in the presence of
ATIII or other plasma inhibitors. When the pulse of thromboplastin FVIIa
activation is over, FIX is the only way to activate FX: it is not broken down
unless heparin is present.
The general picture, therefore, of the importance of FVIII feedback, is that
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either via TF/FVIIa, or via the contact system, FIXa is generated' which then
g"rr;.ut", rxa (Fig. 5). The first traces of thrombin activate FVIII, and FVIIIa
forms a niche on phospholipid for FIXa' When it does not' FlXa can be
attackedbyAllll,butonlyifheparinisthere.Whenthereisnoheparin,FlXa
waits in solution for enoulh FVIIIa to form, then FXa is activated' and the
whole cascade starts'
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